During the past decade, Groupe Hospitalier du Havre conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 3 clinical trials were completed, i.e. on average, 7.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 2 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Groupe Hospitalier du Havre" #1 sponsor was "Groupe Hospitalier du Havre" with 8 trials, followed by "ADIR Association" with 6 trials sponsored, "University Hospital, Rouen" with 6 trials sponsored, "University Hospital, Brest" with 4 trials sponsored and "Federation Francophone de Cancerologie Digestive" with 4 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Groupe Hospitalier du Havre" #1 collaborator was "Celgene Corporation" with 2 trials as a collaborator, "Ministry of Health, France" with 2 trials as a collaborator, "UNICANCER" with 2 trials as a collaborator, "ADIR Association" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Groupe Hospitalier du Havre" are "Chronic Obstructive Pulmonary Disease" (8 trials), "Pulmonary Rehabilitation" (5 trials), "6-minute Stepper Test" (3 trials), "Multiple Myeloma" (3 trials) and "Ankylosing Spondylitis" (2 trials). Many other conditions were trialed in "Groupe Hospitalier du Havre" in a lesser frequency.

Most popular intervention types in "Groupe Hospitalier du Havre" are "Other" (21 trials), "Drug" (16 trials), "Device" (7 trials), "Procedure" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "2 times : 6-minute stepper test with a rest of 20min between each test." (2 trials), "Placebo" (2 trials), "radiation therapy" (2 trials), "vinblastine sulfate" (2 trials) and "2 times : 6-minute stepper test with cardiorespiratory parameters and gaz exchange monitoring (with a rest of 20min between each test)." (1 trials). Other intervention names were less common.

The vast majority of trials in "Groupe Hospitalier du Havre" are 58 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Groupe Hospitalier du Havre". 3 are not yet recruiting, 15 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Groupe Hospitalier du Havre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Groupe Hospitalier du Havre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".

Groupe Hospitalier du Havre has several departments that took part in Clinical trials: "Centre Hospitalier - Pneumologie" - 3 trials, "Hopital Jacques Monod; Dermatologie" - 2 trials